HUM
Humana Inc.NYSEHealthcare$177.85+0.51%OpenMarket Cap: $21.45B
As of 2026-04-06
Valuation
P/E (TTM)
18.05
PEG
—
P/B
1.21
P/S
0.17
EV/EBITDA
10.38
DCF Value
$1,191.99
FCF Yield
1.7%
Div Yield
2.0%
Margins & Returns
Gross Margin
14.5%
Operating Margin
1.1%
Net Margin
0.9%
ROE
6.6%
ROA
3.1%
ROIC
3.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $32.52B | 11.7% | $-1.02B | $-796.0M | $-6.61 | $0.89 |
| FY 2025 | $129.66B | 14.5% | $1.45B | $1.19B | $9.84 | $4.43 |
| Q3 2025 | $32.65B | 14.3% | $108.0M | $195.0M | $1.62 | $1.77 |
| Q2 2025 | $32.39B | 14.9% | $722.0M | $545.0M | $4.51 | $1.77 |
| Q1 2025 | $32.11B | 17.4% | $1.65B | $1.24B | $10.30 | $1.77 |
| Q4 2024 | $29.21B | 13.1% | $-899.0M | $-693.0M | $-5.76 | $1.77 |
| FY 2024 | $117.81B | 14.6% | $1.63B | $1.21B | $9.98 | $4.43 |
| Q3 2024 | $29.40B | 14.5% | $635.0M | $480.0M | $3.98 | $1.77 |
| Q2 2024 | $29.54B | 15.2% | $901.0M | $679.0M | $5.63 | $1.77 |
| Q1 2024 | $29.61B | 15.2% | $990.0M | $741.0M | $6.11 | $1.77 |
| Q4 2023 | $26.46B | 13.9% | $-615.0M | $-541.0M | $-4.42 | $1.77 |
| FY 2023 | $106.44B | 17.0% | $3.32B | $2.49B | $20.00 | $4.33 |